May 22, 2017 08:00 AM Eastern Daylight Time ROCKVILLE, Md.--(BUSINESS WIRE)--Tomorrow, Immunomic Therapeutics, Inc. (ITI) Senior Vice President of Research and Development Teri Heiland, Ph.D., will present on DNA vaccines ...
Immunomic Therapeutics Announces Exclusive License of Phase II Cancer Immunotherapy Technology Targeting Cytomegalovirus (CMV) Immunomic exclusively licensed patent portfolio from Annias Immunotherapeutics for use in combination with Immunomic’s investigational ...
Immunomic Therapeutics and TRIANNI Sign License Agreement for The Trianni Mouse™ May 18, 2017 Eastern Standard Time ROCKVILLE, Md. & SAN FRANCISCO--(BUSINESS WIRE)--Immunomic Therapeutics, Inc. (ITI), a privately held, ...
May is Brain Cancer Awareness Month and Rockville, MD based Immunomic is dedicated to raising awareness and advancing research for this devastating cancer. The facts are grim, over 700,000 Americans ...
May 15, 2017 Immunomic Licenses CMV-Targeting Tech from Annias for LAMP-Vax Cancer Vaccines Immunomic Therapeutics negotiated an exclusive license to Annias Immunotherapeutics’ platform covering technology for targeting cytomegalovirus (CMV) antigens ...
This month, we are celebrating Allergy and Asthma Awareness Month. May is peak season for allergy and asthma sufferers and we want to help raise awareness about the dangers of ...
Midissia Therapeutics to Develop Immune Intensification Technology at Immunomic Labs Last night, Immunomic Therapeutics announced the winner of their Cancer Discovery Incubator Award: Midissia Therapeutics (Midissia). Midissia is a clinical ...
The Importance of National Infant Immunization Week Looking for some good news today? Check out the infant immunization milestones we’ve reached through science: We can now protect infants and children ...
Immunomic Therapeutics Celebrates World Immunization Week This week, we are celebrating World Immunization Week to raise awareness about the importance of following immunization schedules throughout life because when immunization rates ...
Here’s the visual proof of why vaccines do more good than harm By Jia You Apr. 27, 2017, 1:15 PM Vaccines have beat back infectious diseases. Bubbles represent reported U.S. ...
A recent Wall Street Journal article addressed the intersection of two major macro trends within the biotech industry: the rise of China-based innovation-driven biotech companies and the continued sourcing of ...
A new consensus has emerged on the CD4+ helper T cell and its role in facilitating and mediating sustained anti-tumor responses. The importance of this cell population has emerged, in ...